Cogent Biosciences (COGT) Revenue (2017 - 2020)

Cogent Biosciences (COGT) has 4 years of Revenue data on file, last reported at $312000.0 in Q3 2020.

• On a quarterly basis, Revenue fell 69.41% year-over-year to $312000.0 in Q3 2020; TTM through Dec 2020 was $7.9 million, a 65.02% decrease from a year earlier, with the FY2020 full-year figure at $7.9 million, down 65.02% from the prior year.
• Revenue for Q3 2020 stood at $312000.0, down from $528000.0 in the prior quarter.
• Over the last five years, Revenue for COGT reached as high as $15.3 million in Q4 2019 and fell as low as $312000.0 in Q3 2020.
• Historically, Revenue has averaged $3.2 million across 4 years, with a median of $2.1 million in 2017.
• Across the five-year window, Revenue jumped 301.79% in 2019 and plunged 83.17% in 2020, its largest moves.
• Year by year, Revenue stood at $2.1 million in 2017, then soared by 79.23% to $3.8 million in 2018, then soared by 301.79% to $15.3 million in 2019, then slumped by 97.96% to $312000.0 in 2020.
• Per Business Quant data, the three most recent Revenue figures were $312000.0 in Q3 2020, $528000.0 in Q2 2020, and $7.0 million in Q1 2020.